Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Current Taxes (2017 - 2025)

Historic Current Taxes for ProPhase Labs (PRPH) over the last 9 years, with Q3 2025 value amounting to $291000.0.

  • ProPhase Labs' Current Taxes fell 8720.32% to $291000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $291000.0, marking a year-over-year decrease of 8720.32%. This contributed to the annual value of $2.0 million for FY2024, which is 3940.23% down from last year.
  • As of Q3 2025, ProPhase Labs' Current Taxes stood at $291000.0, which was down 8720.32% from $1.4 million recorded in Q2 2025.
  • ProPhase Labs' Current Taxes' 5-year high stood at $8.3 million during Q3 2022, with a 5-year trough of $8000.0 in Q1 2021.
  • Its 5-year average for Current Taxes is $2.8 million, with a median of $2.5 million in 2023.
  • Its Current Taxes has fluctuated over the past 5 years, first skyrocketed by 8473750.0% in 2022, then tumbled by 8720.32% in 2025.
  • ProPhase Labs' Current Taxes (Quarter) stood at $1.3 million in 2021, then soared by 219.36% to $4.2 million in 2022, then fell by 21.74% to $3.3 million in 2023, then plummeted by 39.4% to $2.0 million in 2024, then plummeted by 85.35% to $291000.0 in 2025.
  • Its Current Taxes stands at $291000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $1.5 million for Q1 2025.